NasdaqGM - Delayed Quote USD

ProShares UltraPro Nasdaq Biotechnology (UBIO)

17.77 0.00 (0.00%)
At close: March 27 at 3:59 PM EDT

Performance Overview: UBIO

Trailing returns as of 4/2/2020. Category is Trading--Leveraged Equity.

YTD Return

UBIO
45.70%
Category
--

1-Year Return

UBIO
40.99%
Category
--

3-Year Return

UBIO
13.75%
Category
--

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
UBIO
Category
YTD
-45.67%
0.00%
1-Month
-33.54%
0.00%
3-Month
-45.67%
0.00%
1-Year
-39.33%
0.00%
3-Year
-13.73%
0.00%
5-Year
0.00%
0.00%
10-Year
0.00%
0.00%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
UBIO
Category
2020
--
--
2019
63.12%
--
2018
-40.37%
--
2017
60.04%
--
2016
-63.61%
--
2015
--
--

ETF Summary

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the "index"). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

ETF Overview

Category Trading--Leveraged Equity
Fund Family ProShares
Net Assets 15.09M
YTD Daily Total Return -45.70%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers